First Time Loading...

Circassia Group PLC
LSE:CIR

Watchlist Manager
Circassia Group PLC Logo
Circassia Group PLC
LSE:CIR
Watchlist
Price: 36.5 GBX 0.83% Market Closed
Updated: May 4, 2024
Section:
 

Relative Value

CIR price has not been updated for more than 3 months. This may indicate that the stock has been delisted.

The Relative Value of one CIR stock under the Base Case scenario is 44.11 GBX. Compared to the current market price of 36.5 GBX, Circassia Group PLC is Undervalued by 17%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CIR Relative Value
Base Case
44.11 GBX
Undervaluation 17%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.9
P/S
P/S
Price to Sales
4.9
vs History
7
vs Industry
66
Median 3Y
4.9
Median 5Y
0
Industry
8.3
Forward
4
More Details
9.5
P/E
P/E
Price to Earnings
9.5
vs History
9
vs Industry
10
Median 3Y
9.5
Median 5Y
0
Industry
26.8
Forward
37.3
More Details
22.9
P/OCF
P/OCF
Price to OCF
22.9
vs History
9
vs Industry
8
Median 3Y
22.9
Median 5Y
0
Industry
23.3
More Details
26.7
P/FCFE
P/FCFE
Price to FCFE
26.7
vs History
9
vs Industry
6
Median 3Y
26.7
Median 5Y
0
Industry
21.4
More Details
1.9
P/B
P/B
Price to Book Value
1.9
vs History
30
vs Industry
48
Median 3Y
1.9
Median 5Y
1.9
Industry
2.6
More Details
4.3
EV/S
EV/S
Enterprise Value to Sales
4.3
vs History
9
vs Industry
57
Median 3Y
4.3
Median 5Y
0
Industry
7.5
Forward
3.5
More Details
6
EV/GP
EV/GP
Enterprise Value to Gross Profit
6
vs History
9
vs Industry
53
Median 3Y
6
Median 5Y
0
Industry
9.2
More Details
21
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21
vs History
9
vs Industry
6
Median 3Y
21
Median 5Y
0
Industry
4.5
Forward
19.3
More Details
74.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
74.5
vs History
0
vs Industry
1
Median 3Y
-118
Median 5Y
0
Industry
4.4
Forward
34.3
More Details
20
EV/OCF
EV/OCF
Enterprise Value to OCF
20
vs History
9
vs Industry
8
Median 3Y
20
Median 5Y
0
Industry
5.6
More Details
20.3
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
20.3
vs History
9
vs Industry
7
Median 3Y
20.3
Median 5Y
0
Industry
3.4
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
20
vs Industry
52
Median 3Y
1.7
Median 5Y
1.7
Industry
5
More Details

Multiples Across Competitors

CIR Competitors Multiples
Circassia Group PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Circassia Group PLC
LSE:CIR
153.1m GBP 4.9 9.5 21 74.5
US
Abbvie Inc
NYSE:ABBV
289.2B USD 5.3 60 13 19.9
US
Amgen Inc
NASDAQ:AMGN
166.7B USD 5.9 24.8 17.9 26.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
104.7B USD 8 26.5 17.8 19.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.4B USD 10.5 28.6 22.8 23.9
AU
CSL Ltd
ASX:CSL
133.2B AUD 6.2 35.6 21.6 26.7
US
Gilead Sciences Inc
NASDAQ:GILD
80.7B USD 2.9 166.8 6.7 8.8
US
Moderna Inc
NASDAQ:MRNA
47.8B USD 7 -10.1 -11 -9.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
31.7B USD 3.3 27.1 13.9 17.4
KR
Celltrion Inc
KRX:068270
39.2T KRW 18 73.1 44.7 61.6

See Also

Summary
CIR intrinsic value, competitors valuation, and company profile.
DCF Valuation
CIR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CIR stock valuation using valuation multiples.
Wall Street Estimates
CIR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CIR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.